Patients
TNBC
Between Mar 17, 2017 and Mar 2, 2021, 52 patients were enrolled: 27 in the dose-escalation cohort and 25 in the PK-expansion cohort. Of them, 30 patients had OC and 22 had TNBC (Fig. Trial profileBaseline characteristicsData are n (%) or median (range). 